Lung resection as part of multi-modality treatment for stage IV lung cancer

نویسندگان

چکیده

Background: Some observational studies have demonstrated reasonable survival outcomes for selected patients with stage IV lung cancer undergoing resection as part of multi-modality treatment. We review our experience therapeutic resection.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer.

BACKGROUND The role of surgery after neoadjuvant chemotherapy in patients with stage IIIB non-small cell lung cancer (NSCLC) remains unclear. METHODS A prospective multicenter trial of neoadjuvant chemotherapy followed by surgery or radiotherapy or both was conducted with 41 patients with stage IIIB NSCLC. End points were toxicity, response, downstaging, complete resectability, and survival. ...

متن کامل

Analysis of the Results of Pulmonary Resection by Minimally Invasive Thoracoscopy for the Surgical Treatment of Lung Cancer

Introduction: Lung cancer is the disease of modern era, and the rate of lung cancer mortality is three times as high as that for prostate cancer and twice as high as the rate for breast cancer. We aimed to analyze the results of pulmonary resection in patients with NSCLC by minimally invasive thoracoscopy.  Materials and Methods: We studied 10 patients with NSCLC scheduled for surgical resectio...

متن کامل

Treatment of Stage IV Non-small Cell Lung Cancer

Background: Stage IV non-small cell lung cancer (NSCLC) is a treatable, but not curable, clinical entity in patients given the diagnosis at a time when their performance status (PS) remains good. Methods: A systematic literature review was performed to update the previous edition of the American College of Chest Physicians Lung Cancer Guidelines. Results: The use of pemetrexed should be restric...

متن کامل

Treatment of peripheral early stage lung cancer.

Not only is the incidence of lung cancer increasing around the world, this disease has become the leading cause of cancer death. Since lung cancer kills 85% to 90% of its victims, it is recognized as one of the most difficult to cure diseases. Although the therapeutic results are quite unsatisfactory as a whole, earlier stages of lung cancer, stages IA and IB show better therapeutic results (Ta...

متن کامل

Endoscopic treatment of early-stage lung cancer.

BACKGROUND Disease-free survival after surgical resection of lung carcinoma in situ has been reported as over 90%. After resection of stage IA non-small cell lung cancer, survival at 5 years is approximately 60% to 70%. If endoscopic or bronchoscopic treatments of early-stage lung cancer can provide similar disease-free survival with less perioperative mortality, morbidity, and cost, then they ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Shanghai chest

سال: 2022

ISSN: ['2521-3768']

DOI: https://doi.org/10.21037/shc-22-8